Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise and Liraglutide in Metabolic Syndrome
NCT04575844Phase 4Recruiting
- Sponsor
- University of Virginia
- Start
- Nov 2020
- Primary completion
- Apr 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in metabolic syndrome, sponsored by University of Virginia. Started Nov 2020; status: recruiting.
02
Drugs
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT04575844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575844.